[1] 韩冬. 甲苯急性染毒对小鼠心脏、肝脏影响的初步研究[D]. 太原: 山西医科大学, 2009. [2] LEE G H, LEE H Y, CHOI M K, et al.Protective effect of Curcuma longa L. extract on CCl4-induced acute hepatic stress[J]. BMC Res Notes, 2017, 10(1):1-9. DOI:10.1186/s13104-017-2409-z. [3] 朱安妮, 李蕊, 刘三海, 等. 四氯化碳诱导小鼠急性肝损伤模型的建立和优化[J]. 中国肝脏病杂志(电子版), 2014, 6(1):27-31. DOI:10.3969/j.issn.1674-7380.2014.01.007. [4] DONG S, CHEN Q L, SONG Y N, et al.Mechanisms of CCl4-induced liver fibrosis with combined transcriptomic and proteomic analysis[J]. J Toxicol Sci, 2016, 41(4):561-572. DOI:10.2131/jts.41.561. [5] 刘赴平, 师玲玲. 四氯化碳造成急性肝损伤大鼠模型的实验研究[J]. 中国输血杂志, 2012, 25(5):446-448. DOI:10.13303/j.cjbt.issn.1004-549x.2012.05.025. [6] 班跃松. EC-SOD在大鼠肝缺血再灌注损伤模型心肌内的表达变化[D]. 石家庄: 河北医科大学, 2016. [7] SHARMA P, SHARMA B C.Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction[J]. Saudi J Gastroenterol, 2012, 18(3):168-172. DOI:10.4103/1319-3767.96448. [8] VENKAT D, VENKAT K K.Hepatorenal syndrome[J]. South Med J, 2010, 103(7):654-661. DOI:10.1097/SMJ.0b013e3181e07751. [9] 任晓彦, 万鑫, 杨颖, 等. 不同浓度CCl4 对大鼠肾功能的影响研究[J]. 长治医学院学报, 2019, 33(4):248-251. DOI.10.3969/j.issn.1006-0588.2019.04.003. [10] 魏晓光, 郭辉, 陈永珍, 等. 腹腔注射四氯化碳建立大鼠肝纤维化模型[J]. 实验室研究与探索, 2015, 34(11):34-37. DOI:10.3969/j.issn.1006-7167.2015.11.010. [11] 孙家昌, 孙妩弋, 厉歆然, 等. 不同浓度四氯化碳诱导小鼠肝纤维化模型的比较[J]. 实验动物与比较医学, 2018(4):255-260. [12] OTRUBOVÁ O, TURECKÝ L, ULIČNÁ O, et al. Therapeutic effects of N-acetyl-L-cysteine on liver damage induced by long-term CCl4 administration[J]. Gen Physiol Biophys, 2018, 37(1):23-31. DOI:10.4149/gpb_2017016. [13] 闻名, 卢瑾, 谢元林. 2019冠状病毒病患者合并肝损伤的临床特点[J]. 中南大学(医学版), 2020, 45(5):555-559. DOI:10.11817/j.issn.1672-7347.2020.200225. [14] XIONG X, REN Y, CUI Y, et al.Obeticholic acid protects mice against lipopolysaccharide-induced liver injury and inflammation[J]. Biomed Pharmacother, 2017, 96:1292-1298. DOI:10.1016/j.biopha.2017.11.083. [15] MASHHADI S N Y, ASKARI V R, GHORANI V, et al. The effect of Portulaca oleracea and α-linolenic acid on oxidant/antioxidant biomarkers of human peripheral blood mononuclear cells[J]. Indian J Pharmacol, 2018, 50(4):177-184. DOI:10.4103/ijp.IJP_737_16. [16] BLANKENBERG S, WITTLINGER T, NOWAK B, et al.Troponins as biomarkers for myocardial injury and myocardial infarction[J]. Herz, 2019, 44(1):4-9. DOI:10.1007/s00059-019-4783-x. [17] 甄军海, 李莉, 严静. 脓毒症心肌损伤生物标志物的研究进展[J]. 中华危重病急救医学, 2018, 30(7):699-702. DOI:10.3760/cma.j.issn.2095-4352.2018.07.017. [18] PARADIES G, PARADIES V, RUGGIERO F M, et al.Mitochondrial bioenergetics and cardiolipin alterations in myocardial ischemia-reperfusion injury: implications for pharmacological cardioprotection[J]. Am J Physiol Heart Circ Physiol, 2018, 315(5): H1341-H1352. DOI:10.1152/ajpheart.00028.2018. [19] 邹瑛, 宋金春, 马俊玲. 复方当归注射液对异丙肾上腺素诱导大鼠心肌缺血的保护作用[J]. 中国药师, 2007, 10(1):6-8. DOI:10.3969/j.issn.1008-049X.2007.01.002. [20] LIU X W, LU M K, ZHONG H T, et al.Panax notoginseng saponins attenuate myocardial ischemia-reperfusion injury through the HIF-1α/BNIP3 pathway of autophagy[J]. J Cardiovasc Pharmacol, 2019, 73(2):92-99. DOI:10.1097/fjc.0000000000000640. [21] 牛丹丹, 刘振, 李方方. miR-146 a-5 p通过调控Notch2表达对心肌缺血再灌注模型大鼠心肌损伤的影响[J]. 中国免疫学杂志, 2020, 36(5):530-537, 554. DOI:10.3969/j.issn.1000-484X.2020.05.004. |